With super-enhancers hijacking essential transcription factors (MYC) and chromatin remodelers (NSD2), it may not be surprising that the increased expression and presence of the translated protein could indirectly drive the appearance of H3K4me3-BD over other cancer-associated genes. The gene discussed is MYC; the disease is cancer.